Philip Spiller spent 35 years in the U.S. Food and Drug Administration, 10 as Director of the FDA Office of Seafood and two as Acting Director of the Office of Nutrition, Labeling and Dietary Supplements.
He co-authored the FDA’s preventive control program for seafood safety, which became the model for preventive controls throughout the food industry. Mr. Spiller devoted 10 years to developing an assessment of the effects of fish consumed during pregnancy on fetal neurodevelopment, commonly known as the FDA assessment of net impacts.
In 2023, he co-authored an analysis of how that assessment predicted the beneficial outcomes reported in studies involving over 200,000 mother-child pairs. That analysis appeared in the journal, NeuroToxicology.